WeedMD Inc (CVE:WMD) (OTCQX:WDDMF) (FRA:4WE) said it will begin selling Pedro’s Sweet Sativa, strain-specific PAX ERA products to its Starseed Medicinal clients from March 6, 2021, as part of the launch of its latest Cannabis 2.0 offering, in partnership with cannabis vaporizer technology specialist PAX Labs Inc.
The medical-grade cannabis company said its Starseed Medicinal-branded oil pods in award-winning strain-specific variants, using cannabis-derived terpenes produced in-house, will be available for purchase via its online medical store, while its adult-use Color Cannabis-branded PAX ERA pods are expected to be available through supply arrangements with provincial retailers, commencing in the second quarter of 2021.
READ: WeedMD set to release Mary’s Medicinals topical products in Canada
WeedMD added that its partnership with PAX is expected to further accelerate the growth of its Cannabis 2.0 product strategy as it continued to expand into new formats using its own indoor and outdoor-cultivated biomass, processed at its extraction hub in Aylmer, Ontario.
"In keeping with our long-standing tradition of releasing products first to our medical community, we’re thrilled to launch the PAX ERA line-up in our award-winning Pedro’s Sweet Sativa strain as the latest addition to our growing portfolio,” WeedMD executive chairman and chief executive George Scorsis said in a statement.
“With product features that offer an updated medical experience, our teams worked together over the past few months to finely curate this portfolio of vaporizer products using our premier, quality-produced, strain-specific biomass. We’re looking forward to expanding with additional terpene-rich strains such as Mango Haze and Black Sugar Rose, particularly as our next launch of concentrates will include our adult-use Color Cannabis-branded PAX ERA pods,” he added.
Contact the author at calum@proactiveinvestors.com
Follow him on Twitter @Cal_Proac